ArticleFrontiers in oncology2022

Efficacy and Safety of Capecitabine for Triple-Negative Breast Cancer: A Meta-Analysis.

Xueqiong Xun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.